RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of HIK.L
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Hikma Pharmaceuticals Plc stock price up 0.86% on Wednesday
(Updated on Mar 27, 2024)

Buy candidate since Mar 26, 2024 Gain 0.86% PDF

The Hikma Pharmaceuticals Plc stock price gained 0.86% on the last trading day (Wednesday, 27th Mar 2024), rising from £1,864.50 to £1,880.50. During the last trading day the stock fluctuated 1.37% from a day low at £1,855.00 to a day high of £1,880.50. The price has been going up and down for this period, and there has been a 0.29% gain for the last 2 weeks. Volume fell on the last day by -92 thousand shares and in total, 238 thousand shares were bought and sold for approximately £447.82 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock is at the lower part of a wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at £1,849.56 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect Hikma Pharmaceuticals Plc stock with a 90% probability to be traded between £1,881.85 and £2,133.30 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

HIK.L Signals & Forecast

The Hikma Pharmaceuticals Plc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at £1,896.86 and £1,933.20. A break-up above any of these levels will issue buy signals. Some positive signals were issued as well, and these may have some influence on the near short-term development. A buy signal was issued from a pivot bottom point on Wednesday, March 06, 2024, and so far it has risen 2.15%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Hikma Pharmaceuticals Plc stock

Hikma Pharmaceuticals Plc finds support from accumulated volume at £1,875.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved £25.50 (1.37%) between high and low. For the last week, the stock has had daily average volatility of 2.86%.

Our recommended stop-loss: £1,782.99 (-5.19%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 15 days ago.)

Trading Expectations (HIK.L) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Hikma Pharmaceuticals Plc to open at £1,872.00, and during the day (based on 14 day Average True Range), to move between £1,834.22 and £1,926.78, which gives a possible trading interval of +/-£46.28 (+/-2.46%) up or down from last closing price. If Hikma Pharmaceuticals Plc takes out the full calculated possible swing range there will be an estimated 4.92% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at £1,875.00 (0.29%) than the resistance at £1,939.50 (3.14%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Hikma Pharmaceuticals Plc stock A Buy?

Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.

Current score: 1.337 Buy Candidate Unchanged

Predicted Opening Price for Hikma Pharmaceuticals Plc of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
£1,872.00 ( 0.452%) £1,880.50

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for HIK.L

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1,897.50 0.90 %
R2 1,887.76 0.386 %
R1 1,881.74 0.0660 %
Current price: 1,880.50
Support S1 1,862.26 -0.97 %
S2 1,856.24 -1.29 %
S3 1,846.50 -1.81 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1,994.00 6.04 %
R2 1,965.00 4.49 %
R1 1,939.50 3.14 %
Current price 1,880.50
Support S1 1,875.00 -0.292%
S2 1,855.50 -1.33%
S3 1,847.00 -1.78%

HIK Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Mar 21, 2024 Mar 21, 2024 May 03, 2024 £37.07 1.97%
2 Feb 23, 2023 Mar 23, 2023 May 05, 2023 £29.52 1.58%
3 Aug 04, 2022 Aug 18, 2022 Sep 19, 2022 £16.00 1.28%
4 Feb 24, 2022 Mar 17, 2022 Apr 28, 2022 £26.00 1.28%
5 Aug 06, 2021 Aug 19, 2021 Sep 20, 2021 £13.00 0.545%

FAQ

What is the symbol for Hikma Pharmaceuticals Plc Stock and on which exchange is it traded?
The symbol for Hikma Pharmaceuticals Plc is HIK.L and it is traded on the XLON (London Stock Exchange).

Should I buy or sell Hikma Pharmaceuticals Plc Stock?
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.

How to buy Hikma Pharmaceuticals Plc Stock?
Hikma Pharmaceuticals Plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Hikma Pharmaceuticals Plc Stock.

What's the current price of Hikma Pharmaceuticals Plc Stock?
As of the end of day on the 2024-03-27, the price of an Hikma Pharmaceuticals Plc (HIK.L) share was £1,880.50.

What is the 52-week high and low for Hikma Pharmaceuticals Plc Stock?
The 52-week high for Hikma Pharmaceuticals Plc Stock is £2,222.00 and the 52-week low is £1,627.00.

What is the market capitalization of Hikma Pharmaceuticals Plc Stock?
As of the 2024-03-27, the market capitalization of Hikma Pharmaceuticals Plc is 4.173B.

When is the next earnings date for Hikma Pharmaceuticals Plc?
The upcoming earnings date for Hikma Pharmaceuticals Plc is Aug 08, 2024.
Click to get the best stock tips daily for free!

About Hikma Pharmaceuticals Plc

Hikma Pharmaceuticals Plc Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-in... HIK.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT